Use of interferon beta for acute respiratory distress syndrome: proceed with caution.
Department of Cardiothoracic Pharmacology, National Heart and Lung Institute, Imperial College, London SW3 6LY, UK. Electronic address: p.george@imperial.ac.uk.
Peter M
PM
George
Department of Cardiothoracic Pharmacology, National Heart and Lung Institute, Imperial College, London SW3 6LY, UK.
S John
SJ
Wort
Department of Cardiothoracic Pharmacology, National Heart and Lung Institute, Imperial College, London SW3 6LY, UK.
Jane A
JA
Mitchell
D015720:5'-Nucleotidase / Q000378:metabolism*; D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016899:Interferon-beta / Q000627:therapeutic use*; D008168:Lung / Q000378:metabolism*; D008297:Male; D012128:Respiratory Distress Syndrome / Q000188:drug therapy* / Q000378:metabolism*
D000276:Adjuvants, Immunologic; D016899:Interferon-beta; D015720:5'-Nucleotidase